157 related articles for article (PubMed ID: 29500929)
1. Mapping ligand binding pockets in chloride ClC-1 channels through an integrated in silico and experimental approach using anthracene-9-carboxylic acid and niflumic acid.
Altamura C; Mangiatordi GF; Nicolotti O; Sahbani D; Farinato A; Leonetti F; Carratù MR; Conte D; Desaphy JF; Imbrici P
Br J Pharmacol; 2018 May; 175(10):1770-1780. PubMed ID: 29500929
[TBL] [Abstract][Full Text] [Related]
2. Identification of sites responsible for the potentiating effect of niflumic acid on ClC-Ka kidney chloride channels.
Zifarelli G; Liantonio A; Gradogna A; Picollo A; Gramegna G; De Bellis M; Murgia AR; Babini E; Camerino DC; Pusch M
Br J Pharmacol; 2010 Aug; 160(7):1652-61. PubMed ID: 20649569
[TBL] [Abstract][Full Text] [Related]
3. Role of chloride channels in the regulation of corpus cavernosum tone: a potential therapeutic target for erectile dysfunction.
Chu LL; Adaikan PG
J Sex Med; 2008 Apr; 5(4):813-821. PubMed ID: 18194185
[TBL] [Abstract][Full Text] [Related]
4. Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium.
Liantonio A; Giannuzzi V; Picollo A; Babini E; Pusch M; Conte Camerino D
Br J Pharmacol; 2007 Jan; 150(2):235-47. PubMed ID: 17128287
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of interaction of niflumic acid with heterologously expressed kidney CLC-K chloride channels.
Picollo A; Liantonio A; Babini E; Camerino DC; Pusch M
J Membr Biol; 2007 Apr; 216(2-3):73-82. PubMed ID: 17659402
[TBL] [Abstract][Full Text] [Related]
6. Molecular switch for CLC-K Cl- channel block/activation: optimal pharmacophoric requirements towards high-affinity ligands.
Liantonio A; Picollo A; Carbonara G; Fracchiolla G; Tortorella P; Loiodice F; Laghezza A; Babini E; Zifarelli G; Pusch M; Camerino DC
Proc Natl Acad Sci U S A; 2008 Jan; 105(4):1369-73. PubMed ID: 18216243
[TBL] [Abstract][Full Text] [Related]
7. Targeting kidney CLC-K channels: pharmacological profile in a human cell line versus Xenopus oocytes.
Imbrici P; Liantonio A; Gradogna A; Pusch M; Camerino DC
Biochim Biophys Acta; 2014 Oct; 1838(10):2484-91. PubMed ID: 24863058
[TBL] [Abstract][Full Text] [Related]
8. Chaperone activity of niflumic acid on ClC-1 chloride channel mutants causing myotonia congenita.
Altamura C; Conte E; Campanale C; Laghetti P; Saltarella I; Camerino GM; Imbrici P; Desaphy JF
Front Pharmacol; 2022; 13():958196. PubMed ID: 36034862
[TBL] [Abstract][Full Text] [Related]
9. Conservation of chloride channel structure revealed by an inhibitor binding site in ClC-1.
Estévez R; Schroeder BC; Accardi A; Jentsch TJ; Pusch M
Neuron; 2003 Apr; 38(1):47-59. PubMed ID: 12691663
[TBL] [Abstract][Full Text] [Related]
10. Chloride channel blockers activate an endogenous cationic current in oocytes of Bufo arenarum.
Cavarra MS; del Mónaco SM; Kotsias BA
J Comp Physiol A Neuroethol Sens Neural Behav Physiol; 2004 Jul; 190(7):531-7. PubMed ID: 15103496
[TBL] [Abstract][Full Text] [Related]
11. Channel or transporter? The CLC saga continues.
Pusch M; Zifarelli G; Murgia AR; Picollo A; Babini E
Exp Physiol; 2006 Jan; 91(1):149-52. PubMed ID: 16179405
[TBL] [Abstract][Full Text] [Related]
12. The Cl(-) channel blocker niflumic acid releases Ca(2+) from an intracellular store in rat pulmonary artery smooth muscle cells.
Cruickshank SF; Baxter LM; Drummond RM
Br J Pharmacol; 2003 Dec; 140(8):1442-50. PubMed ID: 14623766
[TBL] [Abstract][Full Text] [Related]
13. Extracellular magnesium and calcium reduce myotonia in isolated ClC-1 chloride channel-inhibited human muscle.
Skov M; De Paoli FV; Lausten J; Nielsen OB; Pedersen TH
Muscle Nerve; 2015 Jan; 51(1):65-71. PubMed ID: 24710922
[TBL] [Abstract][Full Text] [Related]
14. Activation and inhibition of kidney CLC-K chloride channels by fenamates.
Liantonio A; Picollo A; Babini E; Carbonara G; Fracchiolla G; Loiodice F; Tortorella V; Pusch M; Camerino DC
Mol Pharmacol; 2006 Jan; 69(1):165-73. PubMed ID: 16244177
[TBL] [Abstract][Full Text] [Related]
15. Pharmacovigilance database search discloses ClC-K channels as a novel target of the AT
Imbrici P; Tricarico D; Mangiatordi GF; Nicolotti O; Lograno MD; Conte D; Liantonio A
Br J Pharmacol; 2017 Jul; 174(13):1972-1983. PubMed ID: 28334417
[TBL] [Abstract][Full Text] [Related]
16. Chloride channel antagonists perturb growth and morphology of Neurospora crassa.
Hanke GT; Northrop FD; Devine GR; Bothwell JH; Davies JM
FEMS Microbiol Lett; 2001 Jul; 201(2):243-7. PubMed ID: 11470368
[TBL] [Abstract][Full Text] [Related]
17. Association of ClC-3 channel with Cl- transport by human nonpigmented ciliary epithelial cells.
Coca-Prados M; Sánchez-Torres J; Peterson-Yantorno K; Civan MM
J Membr Biol; 1996 Mar; 150(2):197-208. PubMed ID: 8661780
[TBL] [Abstract][Full Text] [Related]
18. Absence of the skeletal muscle sarcolemma chloride channel ClC-1 in myotonic mice.
Gurnett CA; Kahl SD; Anderson RD; Campbell KP
J Biol Chem; 1995 Apr; 270(16):9035-8. PubMed ID: 7721815
[TBL] [Abstract][Full Text] [Related]
19. A selective class of inhibitors for the CLC-Ka chloride ion channel.
Koster AK; Wood CAP; Thomas-Tran R; Chavan TS; Almqvist J; Choi KH; Du Bois J; Maduke M
Proc Natl Acad Sci U S A; 2018 May; 115(21):E4900-E4909. PubMed ID: 29669921
[TBL] [Abstract][Full Text] [Related]
20. Expression of novel isoforms of the CIC-1 chloride channel in astrocytic glial cells in vitro.
Zhang XD; Morishima S; Ando-Akatsuka Y; Takahashi N; Nabekura T; Inoue H; Shimizu T; Okada Y
Glia; 2004 Jul; 47(1):46-57. PubMed ID: 15139012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
